A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults
Clinical trial NCT06783114 · RECRUITING
Trial details
- NCT number
- NCT06783114
- Sponsor
- Chongqing Claruvis Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-14
- Primary completion
- 2026-09-30
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.